Impairment of the HMGB1-RAGE signaling axis by OVesRAGE, an oHSV designed to secrete endogenous secretory RAGE (esRAGE), inhibits MEK-Erk signaling and endothelial cell activation, resulting in enhanced anti-tumor efficacy. This evidence concerns the gene HMGB1 and neoplasm.